JNJ vs RPID · P/E 17, rev $49.37B vs rev $16.1M
Johnson & Johnson (JNJ) versus Rapid Micro Biosystems Inc (RPID) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Rapid Micro Biosystems Inc (RPID) is a medical devices company listed on NASDAQ.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported RPID revenue for 2026-06-30 was $16.1M. Net income was -$27.2M. RPID currently screens at market cap $85.7M.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. RPID currently screens at market cap $85.7M.
Not investment advice. Open the JNJ and RPID stock pages for the full models.
Not investment advice.